Clinical Trial Update: BE.Amycon Registry UZ Leuven

View source ↗

Summary

The BE.Amycon Registry trial at Universitaire Ziekenhuizen KU Leuven is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Amyloidosis | Status: SUSPENDED